{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:37:21Z","timestamp":1792827441956,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuroscience.2026.10.026","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:07:03Z","timestamp":1792166823000},"page":"58-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neurodegenerative diseases in Sub-Saharan Africa: diagnostic invisibility, biological heterogeneity and a precision-neuroscience agenda"],"prefix":"10.1016","volume":"619","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5581-6228","authenticated-orcid":false,"given":"Maulilio John","family":"Kipanyula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.10.026_b0425","doi-asserted-by":"crossref","unstructured":"A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson's disease patients. Exp Biol Med (Maywood). 2026;251:11099. PMID: 42488690.","DOI":"10.3389\/ebm.2026.11099"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.108080","article-title":"Prevalence, characteristics, and clinical outcomes of Huntington's disease in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"141","author":"Aderinto","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.10.026_b0010","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/healthcare13070762","article-title":"Telemedicine adoption and prospects in Sub-Sahara Africa: a systematic review with a focus on South Africa, Kenya, and Nigeria","volume":"13","author":"Agbeyangi","year":"2025","journal-title":"Healthcare (Basel)"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.10.026_b0015","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/brain\/awaf379","article-title":"Large-scale genetic characterization of Parkinson's disease in African and African-admixed populations","volume":"149","author":"Ak\u00e7imen","year":"2026","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.10.026_b0020","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/alz.12432","article-title":"Dementia in Africa: current evidence, knowledge gaps, and future directions","volume":"18","author":"Akinyemi","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-231459","article-title":"Machine learning approaches for dementia detection through speech and gait analysis: a systematic literature review","volume":"100","author":"Al-Hammadi","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0205","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/s41594-024-01423-2","article-title":"African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1","volume":"31","author":"\u00c1lvarez Jerez","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0030","unstructured":"Alzheimer's Disease International, McGill University. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London: Alzheimer's Disease International; 2021."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0035","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/s41467-024-46567-3","article-title":"Looking towards the future of MRI in Africa","volume":"15","author":"Anazodo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.26323","article-title":"Implementation of a teleneurology clinic in Zambia during the COVID-19 pandemic","volume":"91","author":"Asukile","year":"2022","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.026_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0044-1785539","article-title":"Neurology training and medical education in resource-limited settings: building and growing the first neurology residency program in East Africa","volume":"44","author":"Belay","year":"2024","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12877-023-04174-9","article-title":"Prevalence of dementia and its association with central nervous system infections among older persons in northern Uganda: a cross-sectional community-based study","volume":"23","author":"Benyumiza","year":"2023","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/2307443","article-title":"Management practice and clinical outcomes of dementia in Sub-Saharan Africa: a systematic review","volume":"2023","author":"Beyene","year":"2023","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2013.09.010","article-title":"The prevalence and genetics of Parkinson's disease in sub-Saharan Africans","volume":"335","author":"Blanckenberg","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0065","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/ADR-230198","article-title":"The effect of translation and cultural adaptations on diagnostic accuracy and test performance in dementia cognitive screening tools: a systematic review","volume":"8","author":"Czerwinski-Alley","year":"2024","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.10.026_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70220","article-title":"Genetic and environmental risk factors for dementia in African adults: a systematic review","volume":"21","author":"Donkor","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.10.026_b0085","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00415-011-5988-y","article-title":"Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai Tanzania","volume":"258","author":"Dotchin","year":"2011","journal-title":"J Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0090","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.21898","article-title":"The prevalence of Parkinson's disease in rural Tanzania","volume":"23","author":"Dotchin","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0445","unstructured":"Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework. EBioMedicine. 2025. PMID: 41004922."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1179\/2047480615Z.000000000329","article-title":"Writing narrative style literature reviews","volume":"24","author":"Ferrari","year":"2015","journal-title":"Med. Writ."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0395","unstructured":"U.S. Food and Drug Administration, 2024. FDA approves treatment for adults with Alzheimer's disease."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0390","unstructured":"U.S. Food and Drug Administration, 2025. FDA clears first blood test used in diagnosing Alzheimer's disease."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.10.026_b0105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1017\/S1355617724000201","article-title":"Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania","volume":"30","author":"Fotheringham","year":"2024","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"GBD 2021 nervous System Disorders Collaborators","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0115","doi-asserted-by":"crossref","unstructured":"Genomics of Wolfram Syndrome 1 (WFS1). Biomolecules. 2023;13(9):1346. PMID: 37759745.","DOI":"10.3390\/biom13091346"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Info. Libr. J."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000320247","article-title":"Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey","volume":"30","author":"Guerchet","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20694","article-title":"APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians","volume":"59","author":"Gureje","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpsychores.2006.07.016","article-title":"The profile and impact of probable dementia in a sub-Saharan African community: results from the Ibadan study of aging","volume":"61","author":"Gureje","year":"2006","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0140","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., Welch, V.A., (Eds.), 2024. Cochrane handbook for systematic reviews of interventions. Version 6.5. Cochrane."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1477047","article-title":"Preliminary reference values for Alzheimer's disease plasma biomarkers in congolese individuals with and without dementia","volume":"16","author":"Ikanga","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0150","doi-asserted-by":"crossref","unstructured":"Ikanga, J., Obenauf, C., Schwinne, M., Sundaram Patel, S., Gikelekele, G., Epenge, E., et al., 2026. Population attributable fraction of modifiable risk factors for dementia in the Democratic Republic of Congo: a community-based cross-sectional analysis. medRxiv [Preprint]. PMID: 41929346.","DOI":"10.2139\/ssrn.6463723"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.10.026_b0160","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.neurol.2023.11.013","article-title":"Prevalence of multiple system atrophy: a literature review","volume":"180","author":"Kaplan","year":"2024","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120119","article-title":"Why does Africa have the lowest number of neurologists and how to cover the gap?","volume":"434","author":"Kissani","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41746-019-0084-2","article-title":"Digital biomarkers for Alzheimer's disease: the mobile\/wearable devices opportunity","volume":"2","author":"Kourtis","year":"2019","journal-title":"NPJ Digit Med."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/1471-2458-14-653","article-title":"Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review","volume":"14","author":"Lekoubou","year":"2014","journal-title":"BMC Public Health"},{"issue":"7638","key":"10.1016\/j.neuroscience.2026.10.026_b0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0190","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0195","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/gps.3880","article-title":"The prevalence of dementia in rural Tanzania: a cross-sectional community-based study","volume":"28","author":"Longdon","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson's disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.026_b0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/17482968.2011.648644","article-title":"Juvenile and adult-onset ALS\/MND among Africans: incidence, phenotype, survival: a review","volume":"13","author":"Marin","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.10.026_b0215","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2471\/BLT.13.118422","article-title":"Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review","volume":"91","author":"Mavrodaris","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0225","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington's disease: an updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.10.026_b0230","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12877-020-1461-z","article-title":"Prevalence and correlates of Alzheimer's disease and related dementias in rural Uganda: cross-sectional, population-based study","volume":"20","author":"Mubangizi","year":"2020","journal-title":"BMC Geriatr."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.10.026_b0240","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/w16050756","article-title":"Aquatic mercury pollution from artisanal and small-scale gold mining in Sub-Saharan Africa: status, impacts, and interventions","volume":"16","author":"Mulenga","year":"2024","journal-title":"Water"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0245","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.10.026_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.481","article-title":"Prevalence estimates of major neurocognitive disorders in a rural Nigerian community","volume":"6","author":"Ogunniyi","year":"2016","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1468-1331.2000.00124.x","article-title":"Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study","volume":"7","author":"Ogunniyi","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0260","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/mds.21153","article-title":"Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies","volume":"21","author":"Okubadejo","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1024004","article-title":"Epidemiology of neurodegenerative diseases in the East African region: a meta-analysis","volume":"13","author":"Onohuean","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4314\/ahs.v26i1.10","article-title":"Prevalence of dementia among older persons in Northern Uganda, a cross-sectional study","volume":"26","author":"Oriba","year":"2026","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41582-023-00808-z","article-title":"Global synergistic actions to improve brain health for human development","volume":"19","author":"Owolabi","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12877-015-0040-1","article-title":"Validation of the identification and intervention for dementia in elderly Africans (IDEA) cognitive screen in Nigeria and Tanzania","volume":"15","author":"Paddick","year":"2015","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0285","doi-asserted-by":"crossref","first-page":"19646","DOI":"10.3402\/gha.v6i0.19646","article-title":"Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria","volume":"6","author":"Paddick","year":"2013","journal-title":"Glob. Health Action"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.10.026_b0290","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jagp.2014.02.004","article-title":"The prevalence of dementia subtypes in rural Tanzania","volume":"22","author":"Paddick","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.10.026_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70535","article-title":"Alzheimer's association clinical practice guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings","volume":"21","author":"Palmqvist","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.026_b0300","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-74971-4","article-title":"Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts","author":"Pola","year":"2026","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.10.026_b0310","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.10.026_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007791","article-title":"Ancestral origin of APOE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations","volume":"14","author":"Rajabli","year":"2018","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.10.026_b0320","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1002\/alz.13880","article-title":"Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry","volume":"20","author":"Ray","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0325","unstructured":"Reference SVA insertion polymorphisms are associated with Parkinson's disease progression and differential gene expression. NPJ Parkinsons Dis. 2021. PMID: 34035310."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0330","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0335","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","article-title":"Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African-admixed populations: a genome-wide association study","volume":"22","author":"Rizig","year":"2023","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.026_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70508","article-title":"Comparison of proteomic analysis of cerebrospinal fluid from neurological patients with and without amyotrophic lateral sclerosis","volume":"170","author":"Sabetta","year":"2026","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0340","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.26897","article-title":"Role of the exposome in neurodegenerative disease: recent insights and future directions","volume":"95","author":"Sakowski","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0345","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2017.07.037","article-title":"Tele-neurology in sub-Saharan Africa: a systematic review of the literature","volume":"380","author":"Sarfo","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0350","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0435","unstructured":"Serum lipidomics reveals class-specific lipid remodelling and altered acyl chain composition in Parkinson's disease. Parkinsonism Relat Disord. 2026. PMID: 42447690."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0355","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211282119","article-title":"Incident dementia and long-term exposure to constituents of fine particle air pollution: a national cohort study in the United States","volume":"120","author":"Shi","year":"2023","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.026_b0360","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0365","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0375","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of human embryonic stem cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0430","doi-asserted-by":"crossref","unstructured":"The exon-based transcriptomic analysis of Parkinson's disease. Biomolecules. 2025;15(3):440. PMID: 40149977.","DOI":"10.3390\/biom15030440"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.10.026_b0380","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","article-title":"Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"24","author":"Therriault","year":"2025","journal-title":"Lancet Neurol."},{"issue":"5930","key":"10.1016\/j.neuroscience.2026.10.026_b0385","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1126\/science.1172257","article-title":"The genetic structure and history of Africans and African Americans","volume":"324","author":"Tishkoff","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14283\/jarlife.2023.15","article-title":"Prevalence and patterns of cognitive impairment in a sample of community dwelling older people in Nigeria","volume":"12","author":"Ucheagwu","year":"2023","journal-title":"J. Aging Res. Lifestyle."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.026_b0405","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JPD-230409","article-title":"Parkinson's disease in Sub-Saharan Africa: pesticides as a double-edged sword","volume":"14","author":"Urasa","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0410","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/jamaneurol.2025.3307","article-title":"Incidence and prevalence of frontotemporal dementia: a systematic review and meta-analysis","volume":"82","author":"Urso","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0415","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaneurol.2026.1206","article-title":"Incidence and prevalence of dementia with Lewy bodies: a systematic review and meta-analysis","volume":"83","author":"Urso","year":"2026","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.026_b0420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0450","unstructured":"WHO\/AFRO\/UHP:2024-03."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0440","doi-asserted-by":"crossref","unstructured":"Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures. Exp Biol Med (Maywood). 2024;249:10401. PMID: 39844875.","DOI":"10.3389\/ebm.2024.10401"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0460","unstructured":"World Health Organization. Dementia. Fact sheet. Updated 3 July [date as in original submission]."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0475","unstructured":"World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. 2nd ed. Geneva: World Health Organization; [date as in original submission]."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0480","unstructured":"World Health Organization, 2015. Cholinesterase inhibitors and memantine for treatment of dementia. Mental Health Gap Action Programme (mhGAP) Evidence Centre. Updated 2015. Geneva: World Health Organization."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0465","series-title":"Global status report on the public health response to dementia","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0470","series-title":"Intersectoral global action plan on epilepsy and other neurological disorders 2022-2031","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0455","series-title":"Neurological conditions now leading cause of ill health and disability worldwide","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0485","unstructured":"World Health Organization Regional Office for Africa, 2023. Increasing access to quality rehabilitation services in Africa: Regional rehabilitation meeting, 21-23 November 2023, Addis Ababa. Brazzaville: WHO African Region; [date as in original submission]."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0490","unstructured":"World Health Organization Regional Office for Africa, 2024. WHO and Tanzania Ministry of Health take action to improve access to essential medicines for epilepsy and Parkinson disease."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0495","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.puhe.2024.10.035","article-title":"Environmental and occupational exposure to organochlorine pesticides associated with Parkinson's disease risk: a systematic review and meta-analysis based on epidemiological evidence","volume":"237","author":"Xu","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2023.100484","article-title":"High acceptability, convenience and reduced carbon emissions of tele-neurology outpatient services at a regional referral centre in Kenya","volume":"33","author":"Yakub","year":"2023","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.neuroscience.2026.10.026_b0505","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3233\/JAD-240381","article-title":"Prevalence of dementia and cognitive impairment in East Africa region: a scoping review of population-based studies and call for further research","volume":"100","author":"Yenesew","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.10.026_b0510","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/gps.5498","article-title":"Prevalence estimates of dementia in older adults in rural Kilimanjaro 2009-2010 and 2018-2019: is there evidence of changing prevalence?","volume":"36","author":"Yoseph","year":"2021","journal-title":"Int. J. Geriatr. Psychiatry"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:54:27Z","timestamp":1792824867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226006962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":102,"alternative-id":["S0306452226006962"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.10.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegenerative diseases in Sub-Saharan Africa: diagnostic invisibility, biological heterogeneity and a precision-neuroscience agenda","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}